Biochemical Journal 1982-06-15

Effects of adrenaline on ketogenesis from long- and medium-chain fatty acids in starved rats.

M C Sugden, D I Watts, C E Marshall

Index: Biochem. J. 204(3) , 749-56, (1982)

Full Text: HTML

Abstract

1. Injection of adrenaline into 24 h-starved rats caused a 69% decrease in blood [ketone-body] (3-hydroxybutyrate plus acetoacetate), accompanied by a decreased [3-hydroxybutyrate]/[acetoacetate] ratio. Blood [glucose] and [lactate] increased, but [alanine] was unchanged. 2. Adrenaline also decreased [ketone-body] after intragastric feeding of both long- and medium-chain triacylglycerol. The latter decrease was observed after suppression of lipolysis with 5-methylpyrazole-3-carboxylic acid, indicating that the antiketogenic action of adrenaline was not dependent on the chain length of the precursor fatty acid. 3. The actions of adrenaline to decrease blood [ketone-body] and to increase blood [glucose] were not observed after administration of 3-mercaptopicolinate, an inhibitor of gluconeogenesis. This suggests that these effects of the hormone are related. 4. The possible clinical significance of the results is discussed with reference to the restricted ketosis often observed after surgical or orthopaedic injury.


Related Compounds

  • 5-Methyl-1H-pyraz...

Related Articles:

Changes in the plasma concentrations of D-kynurenine and kynurenic acid in rats after intraperitoneal administration of tryptophan enantiomers.

2010-11-01

[Chirality 22 , 901-916, (2010)]

A series of D-amino acid oxidase inhibitors specifically prevents and reverses formalin-induced tonic pain in rats.

2011-01-01

[J. Pharmacol. Exp. Ther. 336 , 282-293, (2011)]

In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties.

2008-03-01

[Eur. Neuropsychopharmacol. 18(3) , 200-14, (2008)]

Plasma prostaglandin levels in rats with diabetes mellitus and diabetic ketoacidosis.

1982-11-01

[Diabetes 31(11) , 994-1001, (1982)]

Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges.

2009-12-01

[Biochem. Pharmacol. 78(11) , 1360-5, (2009)]

More Articles...